Two Sigma Securities’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,200
Closed -$295K 3474
2022
Q3
$295K Buy
+1,200
New +$324K 0.01% 1588
2021
Q1
Sell
-900
Closed -$292K 1925
2020
Q4
$292K Sell
900
-300
-25% -$83K 0.01% 1067
2020
Q3
$332K Sell
1,200
-300
-20% -$86.4K 0.01% 800
2020
Q2
$362K Buy
+1,500
New +$301K 0.01% 783
2020
Q1
Sell
-4,400
Closed -$751K 2528
2019
Q4
$751K Buy
4,400
+2,500
+132% +$463K 0.01% 1209
2019
Q3
$338K Buy
+1,900
New +$411K ﹤0.01% 1456
2019
Q2
Sell
-2,400
Closed -$685K 2519
2019
Q1
$685K Buy
+2,400
New +$798K 0.01% 734

Other funds holding ABMD

Two Sigma Securities's ABMD Position: Q4 2022 in Review

Two Sigma Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,177 shares — an estimated $535K sold.

Two Sigma Securities first reported a position in ABMD in Q4 2017 and held it in 6 quarters. The position peaked at $535K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,177 Abiomed Inc shares in Q4 2022, an estimated $535K.
  • Two Sigma Securities first reported a position in Abiomed Inc in Q4 2017 and held it in 6 quarters.
  • Two Sigma Securities's Abiomed Inc position peaked at $535K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.